CZ69695A3 - The use of non-nucleoside medicament against hiv for preparing a medicament for treating hiv-positive individuals - Google Patents

The use of non-nucleoside medicament against hiv for preparing a medicament for treating hiv-positive individuals

Info

Publication number
CZ69695A3
CZ69695A3 CZ95696A CZ69695A CZ69695A3 CZ 69695 A3 CZ69695 A3 CZ 69695A3 CZ 95696 A CZ95696 A CZ 95696A CZ 69695 A CZ69695 A CZ 69695A CZ 69695 A3 CZ69695 A3 CZ 69695A3
Authority
CZ
Czechia
Prior art keywords
medicament
hiv
preparing
nucleoside
positive individuals
Prior art date
Application number
CZ95696A
Other languages
Czech (cs)
English (en)
Inventor
Wiliam Gary Tarpley
Thomas Jerome Dueweke
Donald Herman Batts
Original Assignee
Upjohn Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Upjohn Co filed Critical Upjohn Co
Publication of CZ69695A3 publication Critical patent/CZ69695A3/cs

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
    • A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CZ95696A 1992-10-28 1993-09-10 The use of non-nucleoside medicament against hiv for preparing a medicament for treating hiv-positive individuals CZ69695A3 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US96763992A 1992-10-28 1992-10-28
US1711993A 1993-02-12 1993-02-12

Publications (1)

Publication Number Publication Date
CZ69695A3 true CZ69695A3 (en) 1995-12-13

Family

ID=26689480

Family Applications (1)

Application Number Title Priority Date Filing Date
CZ95696A CZ69695A3 (en) 1992-10-28 1993-09-10 The use of non-nucleoside medicament against hiv for preparing a medicament for treating hiv-positive individuals

Country Status (12)

Country Link
EP (1) EP0666744A1 (xx)
JP (1) JPH08502745A (xx)
KR (1) KR950703958A (xx)
AU (1) AU4848293A (xx)
CA (1) CA2145545A1 (xx)
CZ (1) CZ69695A3 (xx)
FI (1) FI952018A (xx)
HU (1) HUT72050A (xx)
MX (1) MX9306031A (xx)
NO (1) NO951608L (xx)
PL (1) PL308551A1 (xx)
WO (1) WO1994009781A1 (xx)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
TW406075B (en) * 1994-12-13 2000-09-21 Upjohn Co Alkyl substituted piperidinyl and piperazinyl anti-AIDS compounds
WO2002072548A2 (en) 2001-03-09 2002-09-19 Ortho-Mcneil Pharmaceutical, Inc. Heterocyclic compounds and their use as histamine h4 ligands.
KR20050033662A (ko) 2002-09-06 2005-04-12 얀센 파마슈티카 엔.브이. 헤테로사이클릭 화합물
US8541407B2 (en) 2010-03-31 2013-09-24 Arqule, Inc. Substituted benzo-pyrido-triazolo-diazepine compounds
US8569331B2 (en) 2010-11-01 2013-10-29 Arqule, Inc. Substituted benzo[f]lmidazo[1,2-d]pyrido[2,3-b][1,4]diazepine compounds

Also Published As

Publication number Publication date
CA2145545A1 (en) 1994-05-11
MX9306031A (es) 1994-04-29
HU9501218D0 (en) 1995-06-28
AU4848293A (en) 1994-05-24
KR950703958A (ko) 1995-11-17
FI952018A0 (fi) 1995-04-27
HUT72050A (en) 1996-03-28
WO1994009781A1 (en) 1994-05-11
FI952018A (fi) 1995-04-27
JPH08502745A (ja) 1996-03-26
NO951608L (no) 1995-06-28
EP0666744A1 (en) 1995-08-16
PL308551A1 (en) 1995-08-21
NO951608D0 (no) 1995-04-27

Similar Documents

Publication Publication Date Title
AU2186792A (en) Patient sling
EP0458333A3 (en) Polyisocyanato-isocyanurate, and preparation process and use of the same
LTIP863A (en) Aminobenzodiazepines, process for preparing thereof and application for the treatment and prevention of viral diseases
PL297849A1 (en) Vaccine against and method of treating the patients infectedwith hiv virus
AU7973994A (en) Combination therapy for hiv infection
AU4705193A (en) Medicaments for the treatment or prevention of elevated intraocular pressure
KR100213963B1 (en) Use of 2,3-diaryl-1-benzopyran derivatives for the manufacture of a medicament in the treatment and prevention of bone loss and osteoporosis
SG72610A1 (en) Therapeutic agent from my cobacterium vaccae and its use against hiv infection
AU5848794A (en) Multiple-gene mutants of human immunodeficiency virus (hiv) for vaccine use
AU8824791A (en) Use of xanthines for the preparation of a medicament effective for inhibiting the effects of allograft reaction in humans
AU642751B2 (en) New embodiments of the HIV principal neutralizing determinant
EP0437729A3 (en) New peptides, procedure for their preparation and their use as a medicament, especially their use as medicament against retroviruses
AU1116895A (en) Use of theophylline for the manufacture of a medicament for the treatment of asthma
CZ69695A3 (en) The use of non-nucleoside medicament against hiv for preparing a medicament for treating hiv-positive individuals
EP0592903A3 (en) Use of Ancrod in the manufacture of medications for the treatment of restenosis.
ZA916638B (en) Phosphonopyrrolidine-and piperidine-containing pseudopeptides of the statin type,a process for their preparation and their use as medicaments against retroviruses
EP0338415A3 (en) Use of sulphonylureas in the treatment of oedema
AU8225391A (en) The use of inositolmonophosphate for the preparing of a medicament effective as a neuropeptide gamma-antagonist
AU2880595A (en) Use of pharmaceutical agents for restoring, alleviation, or treatment of immunodeficiency, including the alleviation or treatment of the immune dysfunction related to infection with human immunodeficiency viruses (hiv) or related viruses
EP0418761A3 (en) Locking device between the handgrip arms of medical forceps
AU665052B2 (en) The use of a compound for the manufacture of a medicament for the treatment of HIV infection
IL109447A0 (en) Use of bradykinin antagonists for the preparation of a medicament for the prophylaxis or treatment of arteriosclerosis
EP0711160A4 (en) METHOD OF INHIBITING REPLICATION OF HUMAN IMMUNODEFICIENCY VIRUSES USING SUBSTITUTED AZASPIRANS
IL90894A0 (en) 6-mercaptopurine derivatives,the preparation thereof and the use thereof for controlling retrovirus infections
AU7866894A (en) The use of inositoltrisphosphate for the preparing of medicaments